ROYAL BANK OF CANADA - BELLEROPHON THERAPEUTICS INC ownership

BELLEROPHON THERAPEUTICS INC's ticker is BLPH and the CUSIP is 078771102. A total of 30 filers reported holding BELLEROPHON THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of BELLEROPHON THERAPEUTICS INC
ValueSharesWeighting
Q4 2018$0
-100.0%
56
-94.7%
0.00%
Q3 2018$1,000
-50.0%
1,056
+5.6%
0.00%
Q2 2018$2,000
-98.6%
1,000
-98.6%
0.00%
Q1 2018$147,000
-24.2%
70,866
-5.9%
0.00%
Q4 2017$194,00075,271
+1505320.0%
0.00%
Q3 2017$05
-97.2%
0.00%
Q4 2016$01810.0%0.00%
Q3 2016$01810.0%0.00%
Q2 2016$0181
+18000.0%
0.00%
Q1 2016$010.00%
Other shareholders
BELLEROPHON THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
KLINSKY STEVEN B 4,859,885$44,614,00020.33%
Senator Investment Group LP 448,679$4,119,0000.04%
HIGHLAND CAPITAL MANAGEMENT LP 162,177$1,489,0000.03%
Baker Brothers Advisors 350,000$3,213,0000.03%
Alyeska Investment Group, L.P. 94,131$864,0000.01%
SABBY MANAGEMENT, LLC 30,000$275,0000.01%
FMR LLC 1,302,070$11,953,0000.00%
MILLENNIUM MANAGEMENT LLC 15,427$142,0000.00%
BlackRock Investment Management, LLC 846$8,0000.00%
GOLDMAN SACHS GROUP INC 17,290$159,0000.00%
View complete list of BELLEROPHON THERAPEUTICS INC shareholders